TUCOWS INC /PA/
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Financial Statements
Condensed Consolidated Balance Sheets
(Dollar amounts in thousands of U.S. dollars)
| September 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $54,078 | $56,903 |
| Restricted cash | 4,618 | 4,628 |
| Accounts receivable, net of expected credit losses of $1,045 as of September 30, 2025 and $923 as of December 31, 2024 | 27,981 | 20,878 |
| Deferred costs of fulfillment, current portion | 99,643 | 101,467 |
| Prepaid expenses and other | 22,621 | 21,506 |
| Total current assets | 208,941 | 205,382 |
| Deferred costs of fulfillment, long-term portion | 16,677 | 15,508 |
| Secured notes reserve funds | 12,060 | 11,707 |
| Property and equipment, net | 287,960 | 331,049 |
| Right of use lease asset | 54,413 | 35,640 |
| Intangible assets | 20,978 | 24,755 |
| Goodwill | 130,410 | 130,410 |
| Other assets | 4,052 | 4,345 |
| Total assets | $735,491 | $758,796 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable and accrued liabilities | $32,117 | $40,236 |
| Derivative instrument liability | 568 | 1,270 |
| Operating lease liability, current portion | 5,456 | 5,150 |
| Contract liabilities, current portion | 137,152 | 135,649 |
| Other current liabilities | 19,256 | 17,546 |
| Total current liabilities | 194,549 | 199,851 |
| Contract liabilities, long-term portion | 21,512 | 21,155 |
| Operating lease liability, long-term portion | 48,701 | 25,899 |
| Syndicated revolver | 189,420 | 194,426 |
| Notes payable | 290,642 | 287,646 |
| Redeemable preferred units - no par value, 33,333,333 units authorized; 15,243,600 units issued and outstanding as of September 30, 2025 and December 31, 2024 | 131,763 | 122,156 |
| Deferred tax liability | 2,963 | 2,963 |
| Stockholders' deficit | ||
| Common stock - no par value, 250,000,000 shares authorized; 11,089,663 shares issued and outstanding as of September 30, 2025 and 11,014,655 shares issued and outstanding as of December 31, 2024 | 37,907 | 36,581 |
| Additional paid-in capital | 22,412 | 19,241 |
| Accumulated deficit | (203,947) | (150,158) |
| Accumulated other comprehensive loss | (431) | (964) |
| Total stockholders' deficit | (144,059) | (95,300) |
| Total liabilities and stockholders' deficit | $735,491 | $758,796 |
See accompanying notes to condensed consolidated financial statements
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Dollar amounts in thousands of U.S. dollars, except per share amounts)
| For the Three Months Ended September 30, | For the Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Net revenues | $98,558 | $92,297 | $291,630 | $269,177 |
| Cost of revenues | ||||
| Direct cost of revenues | 57,830 | 52,613 | 172,060 | 155,735 |
| Network, other costs | 5,855 | 7,716 | 17,488 | 21,695 |
| Network, depreciation and amortization | 10,692 | 9,780 | 32,260 | 30,433 |
| Total cost of revenues | 74,377 | 70,109 | 221,808 | 207,863 |
| Gross profit | 24,181 | 22,188 | 69,822 | 61,314 |
| Expenses: | ||||
| Sales and marketing | 11,882 | 15,180 | 34,818 | 48,491 |
| Technical operations and development | 4,682 | 4,615 | 13,433 | 14,153 |
| General and administrative | 9,650 | 11,485 | 28,552 | 30,491 |
| Gain on disposition of property and equipment | (3,965) | - | (5,753) | - |
| Depreciation and amortization | 785 | 955 | 2,537 | 3,342 |
| Impairment of property and equipment | 10,724 | - | 10,724 | - |
| Total expenses | 33,758 | 32,235 | 84,311 | 96,477 |
| Loss from operations | (9,577) | (10,047) | (14,489) | (35,163) |
| Other income (expenses): | ||||
| Interest expense, net | (13,901) | (13,095) | (41,135) | (37,527) |
| Other income, net | 2,915 | 3,919 | 8,722 | 11,373 |
| Total other income (expenses) | (10,986) | (9,176) | (32,413) | (26,154) |
| Loss before provision for income taxes | (20,563) | (19,223) | (46,902) | (61,317) |
| Provision (recovery) for income taxes | 2,456 | 3,074 | 6,887 | 6,068 |
| Net loss for the period | (23,019) | (22,297) | (53,789) | (67,385) |
| Other comprehensive income (loss), net of tax | ||||
| Unrealized income (loss) on hedging activities | (916) | 415 | (239) | (1,015) |
| Net amount reclassified to earnings | 123 | (7) | 772 | (176) |
| Other comprehensive income (loss) net of tax expense (recovery) of ($253) and $134 for the three months ended September 30, 2025 and September 30, 2024, and $174 and ($376) for the nine months ended September 30, 2025 and September 30, 2024. | (793) | 408 | 533 | (1,191) |
| Comprehensive loss, for the period | $(23,812) | $(21,889) | $(53,256) | $(68,576) |
| Basic and diluted loss per common share | $(2.08) | $(2.03) | $(4.87) | $(6.15) |
| Shares used in computing basic and diluted loss per common share | 11,079,486 | 10,982,820 | 11,053,725 | 10,953,778 |
See accompanying notes to the condensed consolidated financial statements
Condensed Consolidated Statements of Cash Flows
(Dollar amounts in thousands of U.S. dollars)
| For the Three Months Ended September 30, | For the Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Cash provided by: | ||||
| Operating activities: | ||||
| Net loss for the period | $(23,019) | $(22,297) | $(53,789) | $(67,385) |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | 11,477 | 10,735 | 34,797 | 33,775 |
| Amortization of debt discount and issuance costs | 1,173 | 1,159 | 3,514 | 3,301 |
| Loss (gain) on disposal of assets | (3,965) | - | (5,753) | - |
| Impairment of property and equipment | 10,885 | 852 | 11,524 | 905 |
| Deferred income taxes (recovery) | 252 | (129) | (170) | 350 |
| Accretion of redeemable preferred units | 9,351 | 1,863 | 9,351 | 9,758 |
| Stock-based compensation expense | 1,387 | 1,808 | 4,278 | 5,383 |
| Change in non-cash operating working capital | ||||
| Accounts receivable | (3,757) | (927) | (7,103) | 3,314 |
| Prepaid expenses and deposits | 1,853 | 4,693 | (370) | 1,312 |
| Deferred costs of fulfillment | 2,641 | (212) | 655 | (5,161) |
| Accounts payable & accrued liabilities | (3,691) | (3,373) | (7,547) | (9,744) |
| Contract liabilities | (4,041) | 455 | 1,860 | 7,946 |
| Other operating assets and liabilities | 988 | 809 | 5,602 | 1,296 |
| Net cash provided by (used in) operating activities | 1,534 | (4,564) | (3,151) | (14,950) |
| Financing activities: | ||||
| Proceeds received on exercise of stock options | - | - | 31 | - |
| Proceeds from issuance of notes payable | - | 62,991 | - | 62,991 |
| Deferred notes payable financing costs | - | (2,011) | - | (2,011) |
| Repayment of syndicated revolver | (2,500) | (2,500) | (5,000) | (14,500) |
| Payment of syndicated revolver costs | (423) | (29) | (423) | (48) |
| Net cash provided by (used in) financing activities | (2,923) | 58,451 | (5,392) | 46,432 |
| Investing activities: | ||||
| Proceeds on disposal of property and equipment and intangible asset | 7,387 | - | 19,023 | - |
| Additions to property and equipment | (3,851) | (14,516) | (12,756) | (44,793) |
| Acquisition of intangible assets | 7 | (478) | (206) | (576) |
| Net cash provided by (used in) investing activities | 3,543 | (14,994) | 6,061 | (45,369) |
| Increase (decrease) in cash and cash equivalents, restricted cash, and restricted cash equivalents | 2,154 | 38,893 | (2,482) | (13,887) |
| Cash and cash equivalents, restricted cash, and restricted cash equivalents beginning of period | 68,602 | 52,198 | 73,238 | 104,978 |
| Cash and cash equivalents, restricted cash, and restricted cash equivalents end of period | $70,756 | $91,091 | $70,756 | $91,091 |
| Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents within the interim consolidated balance sheets to the amounts shown in the interim consolidated statements of cash flows above: | ||||
| Cash and cash equivalents | 54,078 | 75,209 | 54,078 | 75,209 |
| Restricted cash included in funds held by trustee | 4,618 | 4,303 | 4,618 | 4,303 |
| Restricted cash included in secured notes reserve funds | 12,060 | 11,579 | 12,060 | 11,579 |
| Total cash and cash equivalents, restricted cash, and restricted cash equivalents end of period | $70,756 | $91,091 | $70,756 | $91,091 |
| Supplemental cash flow information: | ||||
| Interest paid | $8,464 | $11,352 | $35,271 | $28,856 |
| Income taxes paid, net | $1,140 | $2,451 | $4,531 | $5,278 |
| Supplementary disclosure of non-cash investing and financing activities: | ||||
| Property and equipment acquired during the period not yet paid for | $1,865 | $5,907 | $1,865 | $5,907 |
See accompanying notes to the condensed consolidated financial statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.